Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.

Saved in:
Bibliographic Details
Title: Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.
Authors: Zhou, Hongmei1 (AUTHOR), Zhang, Min1 (AUTHOR), Jin, Yi1 (AUTHOR), Lang, Xianghua1 (AUTHOR) langlingyufanyeah@163.com
Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189876812
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhou%2C+Hongmei%22">Zhou, Hongmei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Min%22">Zhang, Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jin%2C+Yi%22">Jin, Yi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lang%2C+Xianghua%22">Lang, Xianghua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> langlingyufanyeah@163.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Hematology%22">Hematology</searchLink>. Dec2025, Vol. 30 Issue 1, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189876812
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/16078454.2025.2532893
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou, Hongmei
      – PersonEntity:
          Name:
            NameFull: Zhang, Min
      – PersonEntity:
          Name:
            NameFull: Jin, Yi
      – PersonEntity:
          Name:
            NameFull: Lang, Xianghua
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 10245332
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Hematology
              Type: main
ResultId 1